In this interview, Ying-Ying Leung, MB, ChB, MD, answers questions about her team’s recently published article titled “Expert Perspective: Management of the Psoriatic Arthritis Patient After Failure of One...
Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the...
Ikuo Hirano, MD, the Chair of the Writing Committee, answers questions about the ACG/JTF guidelines on the management of patients with eosinophilic esophagitis.
In a new study, researchers sought to clarify how the gut microbe may influence chronic gastrointestinal disease. The coauthors Michael C. Hoaglin, MD, and Melissa Agnello, PhD, answered our questions about...
Edward L. Barnes MD MPH, from the University of North Carolina at Chapel Hill, answers questions about the management of pouchitis in ulcerative colitis, a topic he discussed during his session at the...
While SGLT-2 inhibitors are often used in patients with type 2 diabetes, this class of medication can also be used to treat patients with heart failure. In this Q&A, Jennifer Clements, PharmD, discusses a...
The authors of a recent study examined the safety and clinical efficacy of using mepolizumab to treat patients with HES. First author Florence Roufosse, MD, PhD, answered Consultant360’s questions on the...
Generic medications are becoming an increasingly hot topic, as the cost of prescriptions rise. The authors of a recent study sought to examine the attitudes of health care providers on prescribing generic...
In this Q&A, Marie Bradley, PhD, discusses a recent study in which researchers examined how the benefit risk of apixaban and warfarin varied by age in patients aged less than 65 years with nonvalvular...
Is pulmonary artery denervation via a therapeutic intravascular ultrasonic system a safe and effective treatment option for patients with PAH? In this Q&A, Alex Rothman, BM BCh, PhD, highlights what he and...
